Vicore Webcast: Buloxibutid and the Evolving IPF Landscape

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Untangling the dualistic components of the RAS in PF the Yin and Yang

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

Report on the ATTRACT study